news

Polar distribution of microRNAs discovered within eukaryotic cells

0
SHARES

Posted: 10 June 2015 | Victoria White

Researchers have discovered that certain microRNAs are also asymmetrically distributed within cells and may contribute as cell fate determinants…

A central question in developmental biology is how the original fertilised oocyte gives rise to a complex organism made up of hundreds of different cell types.

The key mechanism is asymmetric cell division that produces daughter cells with uneven distribution of deterministic biomolecules leading to different fates. Certain proteins and messenger RNAs (mRNAs) have previously been identified as cell fate determinants. In a study published in Scientific Reports, the Institute of Biotechnology of the Czech Republic (IBT CAS), the TATAA Biocenter in Sweden, and the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, discovered that certain microRNAs are also asymmetrically distributed within cells and may contribute as cell fate determinants.

This is an important discovery towards our understanding of the complex mechanisms behind asymmetric cell division

Using real-time polymerase chain reaction (qPCR) tomography that the groups developed previously and a new technique for sensitive profiling of microRNAs invented at the EMBL, the team sliced single oocytes from the frog Xenopus laevis across the animal-vegetal (top-down) axis and measured intracellular profiles of microRNAs within the individual cells. Two distinct distributions were found. One, which is likely to form spontaneously, with the microRNAs centered on the nucleus, and one with the microRNAs predominant in the vegetal hemisphere. The first and second divisions of the oocyte are along the animal-vegetal symmetry axis and are not affected by the microRNA gradient discovered, but the third division cuts across producing two sets of four daughter cells that will be different.

Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development. 

In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future. 

Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.

FREE DOWNLOAD HERE

“This is an important discovery towards our understanding of the complex mechanisms behind asymmetric cell division leading to differentiation and the formation of advanced organisms” says Dr Radek Sindelka, group leader at the IBT and one of the lead authors.